92 related articles for article (PubMed ID: 3806169)
1. Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas--a prospective, randomized study.
Rentschler RE; Wilbur DW; Petti GH; Chonkich GD; Hilliard DA; Camacho ES; Thorpe RB
J Clin Oncol; 1987 Feb; 5(2):278-85. PubMed ID: 3806169
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; de Graeff A; Clavel M
J Clin Oncol; 1995 Jul; 13(7):1649-55. PubMed ID: 7602354
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck.
Hong WK; Schaefer S; Issell B; Cummings C; Luedke D; Bromer R; Fofonoff S; D'Aoust J; Shapshay S; Welch J; Levin E; Vincent M; Vaughan C; Strong S
Cancer; 1983 Jul; 52(2):206-10. PubMed ID: 6190545
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.
Browman GP; Goodyear MD; Levine MN; Russell R; Archibald SD; Young JE
J Clin Oncol; 1990 Feb; 8(2):203-8. PubMed ID: 2405105
[TBL] [Abstract][Full Text] [Related]
6. A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.
Eisenberger M; Krasnow S; Ellenberg S; Silva H; Abrams J; Sinibaldi V; Van Echo D; Aisner J
J Clin Oncol; 1989 Sep; 7(9):1341-5. PubMed ID: 2671289
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial.
Browman GP; Levine MN; Goodyear MD; Russell R; Archibald SD; Jackson BS; Young JE; Basrur V; Johanson C
J Clin Oncol; 1988 Jun; 6(6):963-8. PubMed ID: 3286831
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.
Browman GP; Archibald SD; Young JE; Hryniuk WM; Russell R; Kiehl K; Levine MN
J Clin Oncol; 1983 Dec; 1(12):787-92. PubMed ID: 6366132
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate treatment of advanced head and neck cancers: a dose response evaluation.
Woods RL; Fox RM; Tattersall MH
Cancer Treat Rep; 1981; 65 Suppl 1():155-9. PubMed ID: 7034929
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methotrexate and sequential methotrexate-5-fluorouracil for patients with recurrent squamous cell carcinoma of the oral cavity.
Airoldi M; Pedani F; Brando V; Gabriele P; Orecchia R
Chemioterapia; 1987 Dec; 6(6):390-2. PubMed ID: 3435920
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
12. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
[TBL] [Abstract][Full Text] [Related]
13. Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
Dimery IW; Legha SS
J Clin Oncol; 1986 Nov; 4(11):1670-6. PubMed ID: 3095503
[TBL] [Abstract][Full Text] [Related]
14. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials.
Haffty BG; Son YH; Sasaki CT; Papac R; Fischer D; Rockwell S; Sartorelli A; Fischer JJ
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):241-50. PubMed ID: 7691784
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
16. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
18. Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study.
Merlano M; Rosso R; Sertoli MR; Bonelli L; Margarino G; Grimaldi A; Benasso M; Gardin G; Corvó R; Scarpati D
J Clin Oncol; 1988 Apr; 6(4):627-32. PubMed ID: 2451713
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant methotrexate in the radiotherapeutic management of advanced tumors of the head and neck.
Lustig RA; DeMare PA; Kramer S
Cancer; 1976 Jun; 37(6):2703-8. PubMed ID: 949688
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.
Vokes EE; Moran WJ; Mick R; Weichselbaum RR; Panje WR
J Clin Oncol; 1989 Jul; 7(7):838-45. PubMed ID: 2661732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
